Kisqali 400 MG daily dose UU 42S
Ended Awarded Last action
- Contract number
- SPE2DR26FCW9L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,139
Award facts
- Contract value 100% obligated
- $18,138.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Kisqali 400 mg daily dose medication in quantities of 42 units. This $18,138.76 firm fixed-price delivery order, with an ultimate completion date of January 22, 2026, represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications across multiple therapeutic domains to the Defense Health Agency and other government healthcare organizations.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle functions as a comprehensive global pharmaceutical support platform enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical is currently planning the next generation of Pharmaceutical Prime Vendor Global Program contracts, with intentions to award to multiple contractors for separate regions, positioning AmerisourceBergen to continue serving as a significant supplier of critical pharmaceutical commodities to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCW9L?
SPE2DR26FCW9L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FCW9L worth?
The government has obligated $18,139 on SPE2DR26FCW9L.
Is contract SPE2DR26FCW9L an order under another contract?
Yes. SPE2DR26FCW9L is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCW9L competed?
The extent of competition for SPE2DR26FCW9L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award